The Ten Bagger Quest
Massive potential from drug development
By Michael Crockett
This drug discovery company has recently stated that it is increasingly confident that its lead product should be of considerable benefit to millions of patients worldwide. Perhaps this is part of the reason that its shares have shot up by 50% in the last few weeks.
AimZine explains why this company has good reason to be confident of future success and considers the financial implications of such success.
Follow Investors Champion’s comments on small caps daily on the Investors Champion Blog.
NOTE: This article is copyright of Investors Champion. No part should be copied, reproduced or distributed in any way without prior consent.
Synairgen (AIM: SNG)
http://www.synairgen.com/
Introduction
Synairgen is a drug discovery company founded by three professors from the University of Southampton. The Company is based at Southampton General Hospital. Synairgen’s focus is on developing new treatments for severe respiratory conditions. Over a 10 year period the Company has invested considerable time and money in developing its lead product, inhaled Interferon Beta (IFN-Beta), for use by Asthma and COPD patients, particularly when…
